Neuros Co., Ltd. (KOSDAQ:A126870) announced a private placement of 7th series unregistered and unsecured private convertible bonds for gross proceeds of KRW 8,500,000,000 on April 30, 2018. The bond will mature on May 3, 2021. The bonds are carry a zero present and yield to maturity 2% per annum. The bonds fully convertible into 1,022,987 common shares at a conversion price of KRW 8,309 per share from May 3, 2018 to end date April 3, 2021. The transacton will include participation from existing investors, Korea Securities Finance Corporation, Investment Arm, NH Investment & Securities Co., Ltd., Asset Management Arm, Korea Investment & Securities Co., Ltd., Investment Arm, and other investors, BFA Co.,Ltd., Shinhan Investment Corp., Investment Arm, and Samsung Securities Co. Ltd., Investment Arm. The board of directors of the company have approved the transaction.